Wednesday , October 23 2019

Harley rises as motorcycle maker cuts spending during sales slump

Bloomberg Harley-Davidson Inc profit beat estimates as the motorcycle maker pared back spending plans to partially offset shrinking sales in the US, its biggest market. Adjusted earnings fell to 70 cents a share in the third quarter, the Milwaukee-based manufacturer said in a statement Tuesday, exceeding analysts’ average estimate for ...

Read More »

Biogen surges 22% over momentum for Alzheimer’s therapy

Bloomberg Biogen Inc will ask US drug regulators to approve the company’s experimental Alzheimer’s therapy, reviving the nearly abandoned treatment after a new analysis of data from two failed clinical trials showed promising results. The company said it made the decision after talking with the Food and Drug Administration (FDA), ...

Read More »

Novartis boosts forecast again as new gene therapy shines

Bloomberg Novartis AG raised its earnings forecast for the third time this year as new drugs including gene therapy Zolgensma got off to a strong start. Sales of the world’s most expensive drug beat analysts’ estimates with more than 100 children treated since Zolgensma’s May approval. Novartis said plans are ...

Read More »